In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy (2019)
- Authors:
- USP affiliated authors: MARCHETTI, JULIANA MALDONADO - FCFRP ; EMERY, FLAVIO DA SILVA - FCFRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; GASPARI, PRISCYLA DANIELY MARCATO - FCFRP ; LUIZ, MARCELA TAVARES - FCFRP ; ABRIATA, JULIANA PALMA - FCFRP ; RASPANTINI, GIOVANNI LOUREIRO - FCFRP ; TOFANI, LARISSA BUENO - FCFRP ; FUMAGALLI, FERNANDO - FCFRP ; MELO, SHAIANI MARIA GIL DE - FCFRP
- Unidade: FCFRP
- DOI: 10.1016/j.msec.2019.110038
- Subjects: QUIMIOTERAPIA; ÁCIDO FÓLICO; NEOPLASIAS OVARIANAS; NANOPARTÍCULAS
- Keywords: Active targeting; Chemotherapy; Folic acid; Nanocarrier; Ovarian cancer; Polymeric nanoparticles
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Materials Science & Engineering C
- ISSN: 1873-0191
- Volume/Número/Paginação/Ano: v. 105, p. e110038, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LUIZ, Marcela Tavares et al. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Materials Science & Engineering C, v. 105, p. e110038, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2019.110038. Acesso em: 27 dez. 2025. -
APA
Luiz, M. T., Abriata, J. P., Raspantini, G. L., Tofani, L. B., Fumagalli, F., Melo, S. M. G. de, et al. (2019). In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Materials Science & Engineering C, 105, e110038. doi:10.1016/j.msec.2019.110038 -
NLM
Luiz MT, Abriata JP, Raspantini GL, Tofani LB, Fumagalli F, Melo SMG de, Emery F da S, Swiech K, Marcato PD, Lee R, Marchetti JM. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy [Internet]. Materials Science & Engineering C. 2019 ; 105 e110038.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.msec.2019.110038 -
Vancouver
Luiz MT, Abriata JP, Raspantini GL, Tofani LB, Fumagalli F, Melo SMG de, Emery F da S, Swiech K, Marcato PD, Lee R, Marchetti JM. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy [Internet]. Materials Science & Engineering C. 2019 ; 105 e110038.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.msec.2019.110038 - Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays
- Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles
- PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization
- Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis
- Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment
- Comparative analysis of 3d bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening
- Synthesis and structure−activity relationships of imidazopyridine/pyrimidine- and furopyridine‐based anti‐infective agents against Trypanosomiases
- Decorating BODIPY with electron-withdrawing NO group: spectroelectrochemical consequences and computational investigation
- Synthesis and characterization of two novel red-shifted isothiocyanate BODIPYs and their application in protein conjugation
- A review of the synthetic strategies toward Dihydropyrrolo [1,2-a] Pyrazinones
Informações sobre o DOI: 10.1016/j.msec.2019.110038 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003020896.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
